Stephen Mitchener

The past year has seen a wealth of high-stake radiopharmaceutical M&As and investments, but what are the drivers of investor interest, and will these trends continue? Assessing how the growing market and high returns potential could unlock support for smaller biotech while identifying potential challenges.

Hear from the funding experts themselves on:

• Digging down on what the investors are interested in from targeting moiety, platform technology to payload
• Learning from industry stories to understand what it takes for a high-stakes investment
• Understanding what enhances radiopharmaceuticals commercial viability to attract more investment
• Exploring how to position and distinguish your technology’s platform capabilities